Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein and anion channel that functions primarily as a chloride and bicarbonate ion channel across epithelial cell membranes. Dysfunction of CFTR leads to cystic fibrosis, a common lethal genetic disease. Recent advances include CFTR modulators, small molecule drugs that either potentiate defective channels or increase their presence at the cell surface, improving clinical outcomes.
CFTR modulators potentiate defective channels or increase their presence at the cell surface.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cystic Fibrosis Transmembrane Conductance Regulator (None).